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Introduction
Circulatory shock is common and associated with high 
morbidity and mortality. Th e word ‘shock’ is an old term, 
often attributed to the French surgeon Henri LeDran, 
although it is interesting that the actual word ‘choc’ never 
appeared in the French version of his thesis [1], but only 
in the English translation [2], in which ‘shock’ was used 
to translate the French words ‘saisissement’, ‘commotion’, 
and ‘coup’ [3]. It was not until 1827 that an English 
surgeon, George Guthrie, fi rst used the word ‘shock’ in 
association with a physiological response to injury [4]. 
Understanding of the mechanisms underlying shock and 
the description and classifi cation of shock states came 
much later and one of the key early contributors to this 
fi eld was Dr Max Harry Weil, who died last year [5]. In 
this article, we provide a brief update on circulatory 
shock, building on the foundations laid by Dr Weil.
Clinical identifi cation of shock states
Shock is best defi ned as ‘acute circulatory failure’, as Dr 
Weil proposed [6], a situation in which the circulation 
fails to provide cells with suffi  cient oxygen to be able to 
perform optimally. Clinically, arterial hypotension is a 
cardinal sign, but not always present because general 
vasoconstriction caused by the activated sympathetic 
nervous system may mask the fall in blood pressure. Th e 
usual lower limit for systolic arterial pressure is 
considered as 90 mmHg, but this is an arbitrary value 
and may vary from one patient to another - for example, 
the pressure threshold may be lower in younger than in 
older individuals.
Weil and colleagues highlighted the importance of 
blood lactate concentrations in patients with shock many 
years ago [7,8], and lactate concentrations remain one of 
the most useful biological tests in this setting. Normal 
concentrations are around 1  mEq/L (or mmol/L), and a 
value above 2 mEq/L is considered to refl ect the presence 
of shock (Figure  1). Importantly, in a recent study, 
mortality was increased even in those who had small 
increases in lactate concentration to between 1.5 and 
2.0  mEq/L [9]. Although generally associated with 
anaerobic metabolism, raised lactate concentrations may 
also occur as a result of excessive aerobic glycolysis (for 
example, during shivering, seizures, hyperventilation) 
and/or decreased utilization (for example, liver failure, 
mitochondrial inhibition). Nevertheless, in the context of 
altered tissue perfusion, the severity of hyperlactatemia is 
directly related to outcome [10,11]. In addition to single 
measurements, changes in lactate concentrations over 
time may have additional predictive value for organ 
failure and mortality [12].
When assessing the damage an earthquake or fi re has 
caused inside a building, one looks through the windows. 
Using this analogy, it would be useful to be able to see 
inside the body to view the damage caused by the shock 
process. Clearly this is not possible, but the skin, the 
kidneys and the brain provide us with three types of 
‘window’ through which we can see the eff ects of the 
altered tissue perfusion: through the skin ‘window’, we 
can see decreased capillary fl ow, slow refi ll, cold and 
clammy skin [13]; through the kidney ‘window’, we 
typically see oliguria <0.5  mL/kg/h; and through the 
brain ‘window’, we see obtundation/disorientation/
confusion that was not present before the shock episode 
(Figure  2). Unfortunately, we currently have no other 
‘windows’ (for example, it would be nice to visualize the 
gut and liver, but this is not possible practically; gastric 
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tonometry and dye-clearance were tried but their role 
was never clearly defi ned and they are not commercially 
available). Th e sublingual microcirculation (see below) 
may provide us with a new ‘window’. Th is ‘window’ has 
been used in several studies [14-18] and has been shown 
to have high sensitivity for identifying the presence of 
shock and response to therapy [15]. Although current 
equipment is not yet suitable for routine clinical use, 
improvements in the available technology together with 
supportive clinical trials may make this a valuable 
window to identify and treat diff erent states of shock.
Figure 3 shows the interaction between arterial pressure, 
altered tissue perfusion, increased lactate and micro-
vascular alterations.
Classifi cation of shock states
Shubin and Weil [19] defi ned the pathophysiological 
states of circulatory shock many years ago, using a 
classifi cation based on four mechanisms (Table  1, 
Figure 4). In the fi rst three types, cardiac output is low. In 
fact, each of the three types is represented by one of the 
determinants of cardiac output: decreased preload 
(hypovolemic), altered contractility (cardiogenic), and 
increased afterload (obstructive). In the fourth type of 
shock, the distributive defect is the result of the release of 
many mediators, including cytokines. Th ese mediators 
can have vasodilating and vasopressor eff ects, although 
vasodilating eff ects predominate in the central circula-
tion. Some of these mediators decrease myocardial con-
tract ility, accounting for the myocardial depression 
associated with sepsis. Despite this myocardial depres-
sion, distributive shock in humans is generally associated 
with an increase in cardiac output. Th ere is also 
microvascular obstruction because of activated leuko-
cytes and platelets impairing the distribution of blood 
fl ow in the periphery. Moreover, because of a defect in 
the microvasculature, autoregulatory mecha nisms are no 
longer eff ective in matching oxygen need to oxygen 
supply and there is an increased shunt of the micro-
circulation. Th e resultant increased heterogeneity of 
micro circulatory perfusion creates areas of no fl ow in 
close proximity to areas of fl ow. Importantly, although 
the focus of this review is circulatory shock, it must be 
appreciated that infl ammatory mediators and oxidative 
stress from circulatory shock and reperfusion or due to 
other factors (for example, sepsis) can also directly cause 
tissue injury.
Put in very basic terms, something is wrong with the 
pump (cardiogenic), with the volume (hypovolemic), with 
the major vessels (high afterload/obstruction) or with the 
small vessels (distributive/shunting).
Importantly, diff erent types of shock may co-exist. For 
example, in sepsis there may be a combination of distri-
butive, hypovolemic (sweating, diarrhea, extravasation 
and so on) and even cardiogenic forms; in anaphylactic 
shock the same pattern may be present, that is, distri-
butive and hypovolemic (due to severe permeability 
alterations) with altered myocardial contractility.
Microvascular alterations
Microvascular alterations are common in all shock states. 
In distributive types of shock we expect these changes, 
but they can also be observed in cardiogenic shock states 
[20].
Microcirculatory alterations caused by pathogenic 
factors and hemodynamic changes are critically involved 
in the eff ects of shock on organ function as oxygen trans-
port to the cells becomes compromised due to limitation 
of convective (fl ow) and/or diff usive (increased distance 
between cells and red blood cell-carrying capillaries) 
Figure 2. The three ‘windows’ on shock.
Figure 1. The importance of blood lactate concentrations in 
determining the presence of shock.
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transport of oxygen to the tissues [21]. Cellular altera-
tions of the microcirculation include endothelial dysfunc-
tion [22], changes in the hemorheological properties of 
red blood cells [23], leukocyte activation, coagulopathy 
and vascular smooth muscle cell alterations causing auto-
regulatory dysfunction. Endothelial glyco calyx shedding 
[24], which is highly sensitive to oxidative stress, contri-
butes to the compromise of the endothelial vascular 
barrier, resulting in tissue edema [25]. From this pers pec-
tive, the microcirculation could indeed be regarded as a 
target of shock. Microcirculatory areas with obstructions 
are shunted, resulting in patchy, hetero geneous hypoxic 
areas [26]. In addition, cellular changes occur, involving 
mitochondrial depression [27]. Although this had been 
clearly identifi ed from animal studies, the true extent to 
which the above occurred in the clinical setting remained 
unclear until the late 1990s when the introduction of 
hand-held video microscopes allowed direct bedside 
observations of the microcirculation [28]. Heterogeneity 
of microvascular fl ow among organs and within the 
microcirculation, independent of systemic hemodynamic 
variables, is a characteristic of the micro circulatory 
altera tions seen in human sepsis [16] and capillary ob-
struction is observed in the presence of normal fl ow in 
larger vessels [14,29]. Th ese observations are a direct 
demon stration of the presence of shunting occurring at 
the microcirculatory level and give new credence to Dr 
Weil’s appreciation of circulatory shunt ing as being a key 
feature of distributive shock [19].
Importantly, studies have demonstrated that persistent 
sublingual microcirculatory alterations are associated 
with adverse outcomes in patients with septic shock [29], 
and that resuscitation therapies, which are eff ective in 
the early recruitment of the microcirculation, can 
improve organ function and outcome in septic shock 
patients [15,18]. It may, therefore, be that, for early goal-
directed therapy to be eff ective in patients with shock, it 
must be able to recruit the microcirculation. However, 
current technology for monitoring the microcirculation 
is not yet ready for the clinical arena and further clinical 
trials in diff erent patient groups are needed before the 
microcirculation can really present itself as a window to 
monitor and treat shock.
Principles of therapy
Dr Weil introduced the VIP rule (V for ventilate, I for 
infuse, and P for pump) many years ago [30] for the initial 
resuscitation of shock, but it is still relevant today.
Ventilation
Adequate oxygenation is of course essential but there is 
some debate about the use of excessive PaO2 with 
suggestions that it may alter the microcirculation, 
Figure 3. The triangular basis of circulatory shock. The full 
clinical picture includes the three features of hypotension, altered 
tissue perfusion and hyperlactatemia, whereas the underlying 
microcirculatory disturbances are less apparent. However, the 
systemic presentation is not always complete.
Table 1. The four pathophysiological types of shock and 
their principal causes
Pathophysiological type Cause
Hypovolemic Hemorrhage, trauma
 Dehydration
 
Cardiogenic Myocardial infarction
 Cardiomyopathy
 Valvular disease
 Severe arrhythmias
 
Obstructive Pulmonary embolism
 Tamponade
 Aortic dissection
 
Distributive Infl ammatory response (mediators)
Figure 4. The four types of acute circulatory failure according to 
Weil and Shubin. Reproduced from [19], with permission.
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primarily by inducing vasoconstriction and generating 
oxygen radicals. After cardiac arrest, in particular, high 
PaO2 may be deleterious [31]. Th e problem in shock is 
that the widely used, readily available indication of 
arterial saturation, pulse oximetry, may not be reliable 
because of the altered skin perfusion that occurs with 
major vasoconstriction; hence, to avoid the well-known 
risks associated with hypoxia, we tend to be relatively 
generous with oxygen administration. Importantly, if 
there is any question about whether or not a patient 
needs endotracheal intubation, then this procedure 
should be performed and not delayed. Non-invasive 
mechanical ventilation should be used with caution in 
hemodynamically unstable patients.
Infuse
Fluids should not be withheld based just on the presence 
of edema, because edema formation may be the result of 
extravasation of fl uids, which decreases blood volume, an 
eff ect demonstrated by Dr Weil decades ago [32]. It is 
also well known that static values of eff ective fi lling 
(pressures or volumes) are a poor predictor of the 
response to fl uids [33,34], so fl uids should not be 
withheld based on these measures. Fluid challenges with 
pre-set limits can help determine the need for ongoing 
fl uid infusion, as suggested by Dr Weil [35]. Optimal 
choice of fl uid remains debated, although recent studies 
in patients with severe sepsis suggest that 4% albumin 
solutions may be of benefi t compared to normal saline 
[36] and hydroxyethyl starch solutions may increase 
mortality compared to Ringer’s acetate [37]. Th ere is 
some controversy about the use of saline solutions in the 
presence of severe metabolic acidosis, because of the 
chloride load.
Pump
Pump eff ectively refers to the use of vasoactive agents. 
Vasopressors should be given fi rst to maintain a minimal 
perfusion pressure, even if there is cardiogenic shock, 
because dobutamine administration may result in hypo-
tension if there is any degree of hypovolemia. Vaso-
pressors are generally started early, at the same time as 
fl uids, but patients are weaned from vasopressor support 
as soon as possible. Norepinephrine is preferred over 
dopamine, as it is associated with lower mortality rates in 
cardiogenic [38] and in septic [39] shock.
Conclusion
Dr Weil set the basis for much of today’s current know-
ledge of circulatory shock. Th erapy for shock should be 
based on pathophysiological alterations rather than on 
protocols. Monitoring of shock relies on assessment of 
arterial pressure, cardiac output, tissue perfusion abnor-
malities, and blood lactate concentrations. Monitoring of 
the microcirculation may help, but further study is 
needed to confi rm this.
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